Tags: chemotherapycarboplatincisplatincancerlong-term
| Profile | Contacts | Recent Articles on Subject | |
|---|---|---|---|
| 1 | Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. | ||
| 2 | Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey | ||
| 3 | Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York | Immunotherapy Combo Active in Advanced PD-L1-Negative HNSCC - 4 months ago First-Line Nivolumab Plus Chemo Approved for Bladder Cancer - 9 months ago Novel Therapy Promising for Radiation-Induced Oral Mucositis - 9 months ago Futile Immunotherapy for Cancer Grows More Common - 11 months ago | |
| 4 | Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. | KEYNOTE-A18 Data Are 'Practice-Changing' for Cervical Cancer - 11 months ago Uterine Cancer Trials Made Waves This Year, Experts Say - 12 months ago | |
| 5 | Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey | ||
| 6 | Mike Hennessy Jr, President and CEO Pharmacy Times Pro middleweight boxer. UK/Ireland. | ||
| 7 | Clare Wilson New Scientist Science news source. Worldwide | ||
| 8 | Angus Chen STAT News Undignified, unfunny journalist. Health, cancer coverage at STAT News. | ||
| 9 | Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia | ||
| 10 | Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland | Dostarlimab Plus Chemotherapy Demonstrates Significant Overall Survival Benefit in Endometrial Cancer - 8 months ago |